Thomas A. Rasmussen
Aarhus University(DK)Aarhus University Hospital(DK)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Immune Cell Function and Interaction, HIV-related health complications and treatments
Most-Cited Works
- → Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial(2014)635 cited
- → The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo(2015)519 cited
- → Comparison of HDAC inhibitors in clinical development(2013)190 cited
- → Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial(2016)175 cited
- → Shocking HIV out of hiding(2016)149 cited
- → Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection(2017)145 cited
- → HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission(2015)118 cited
- → Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir(2011)106 cited
- → A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells(2016)101 cited
- → Reversal of Latency as Part of a Cure for HIV-1(2015)98 cited